rs368075301
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_StrongBP6BP7
The NM_001005361.3(DNM2):c.216G>A(p.Gln72Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,614,000 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001005361.3 synonymous
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant centronuclear myopathyInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Charcot-Marie-Tooth diseaseInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Charcot-Marie-Tooth disease dominant intermediate BInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
- autosomal dominant Charcot-Marie-Tooth disease type 2MInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- fetal akinesia-cerebral and retinal hemorrhage syndromeInheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- hereditary spastic paraplegiaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNM2 | NM_001005361.3 | c.216G>A | p.Gln72Gln | synonymous_variant | Exon 2 of 21 | ENST00000389253.9 | NP_001005361.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DNM2 | ENST00000389253.9 | c.216G>A | p.Gln72Gln | synonymous_variant | Exon 2 of 21 | 5 | NM_001005361.3 | ENSP00000373905.4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152136Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251488 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461864Hom.: 1 Cov.: 31 AF XY: 0.0000206 AC XY: 15AN XY: 727236 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152136Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74312 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Charcot-Marie-Tooth disease dominant intermediate B Benign:1
- -
DNM2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at